Roble Belko & Company’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$734K Buy
30,293
+6,485
+27% +$157K 0.08% 72
2026
Q1
$577K Buy
23,808
+1
+0% +$24 0.07% 77
2025
Q4
$577K Buy
23,807
+3
+0% +$73 0.08% 76
2025
Q3
$578K Buy
23,804
+1,032
+5% +$25K 0.08% 75
2025
Q2
$552K Buy
22,772
+2
+0% +$48 0.08% 75
2025
Q1
$551K Buy
22,770
+1
+0% +$24 0.09% 71
2024
Q4
$548K Buy
22,769
+7,855
+53% +$189K 0.09% 70
2024
Q3
$362K Buy
14,914
+791
+6% +$19K 0.06% 84
2024
Q2
$336K Buy
14,123
+2
+0% +$47 0.06% 85
2024
Q1
$337K Buy
14,121
+1
+0% +$24 0.06% 84
2023
Q4
$337K Buy
14,120
+183
+1% +$4.3K 0.06% 72
2023
Q3
$325K Buy
13,937
+3,832
+38% +$89.7K 0.07% 72
2023
Q2
$237K Hold
10,105
0.05% 78
2023
Q1
$240K Hold
10,105
0.05% 83
2022
Q4
$236K Hold
10,105
0.05% 87
2022
Q3
$233K Hold
10,105
0.06% 81
2022
Q2
$240K Hold
10,105
0.05% 83
2022
Q1
$249K Hold
10,105
0.05% 91
2021
Q4
$263K Hold
10,105
0.05% 86
2021
Q3
$268K Hold
10,105
0.06% 74
2021
Q2
$269K Hold
10,105
0.06% 80
2021
Q1
$266K Hold
10,105
0.06% 74
2020
Q4
$274K Hold
10,105
0.07% 70
2020
Q3
$271K Hold
10,105
0.08% 70
2020
Q2
$270K Hold
10,105
0.08% 71
2020
Q1
$248K Hold
10,105
0.08% 79
2019
Q4
$258K Buy
10,105
+3,286
+48% +$83.6K 0.07% 79
2019
Q3
$174K Buy
6,819
+2,510
+58% +$63.4K 0.05% 97
2019
Q2
$108K Buy
4,309
+2,539
+143% +$62K 0.03% 115
2019
Q1
$43K Buy
+1,770
New +$41.9K 0.01% 125

Other funds holding IBDR

Roble Belko & Company's IBDR Position: Q2 2026 in Review

Roble Belko & Company increased its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 27% in Q2 2026, buying an estimated $157K and bringing the position to 30,293 shares worth $734K. The position accounts for 0.08% of the portfolio, ranked #72.

Roble Belko & Company first reported a position in IBDR in Q1 2019 and has held it in 30 quarters since. 422 funds tracked by Wall St. Rank hold IBDR as of Q2 2026.

  • Roble Belko & Company held 30,293 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $734K as of Q2 2026.
  • Roble Belko & Company bought 6,485 iShares iBonds Dec 2026 Term Corporate ETF shares in Q2 2026, an estimated $157K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.08% of Roble Belko & Company's portfolio in Q2 2026, its #72 holding.
  • Roble Belko & Company first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2019 and has held it in 30 quarters since.
  • 422 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.